Fidanacogene

Follow-up of Patients With Hemophilia B Treated With Fidanacogene Elaparvovec AAV Gene Therapy

ISTH

Innovation in Hemophilia Treatment | DoM Grand Rounds | 20 September 2023

Stanford Department of Medicine

Gene Therapy: An End to Hemophilia

Demystifying Medicine McMaster

Health-related Quality of Life in Adults With Hemophilia B After Gene Therapy

ISTH

Results From the Phase 3 BENEGENE-2 Gene Therapy Trial

ISTH

Spark Therapeutics' Pipeline Overview

When the Immune System Attacks!

National Bleeding Disorders Foundation

Dr. Barbara Konkle discusses the Alta Study

ISTH

Practice-Changing Advances in the Management of Hemophilia

Efficacy and Safety of Etranacogene Dezaparvovec: First Data From the Phase 3 Hope-B Trial

GENEr8-1 Two-Year Analysis as presented at EAHAD

ISTH

Gene Therapy: What's New & What's Next

National Bleeding Disorders Foundation

Valoctocogene Roxaparvovec AAV Gene Transfer for Severe Hemophilia: Results From Phase 3 Trial

ISTH

Advancements in Treatment for Hemophilia: What You Need to Know

National Bleeding Disorders Foundation

young patient with Hemophilia

Prof Dr Khalid Farooq

Pharma News Today 1st January 2023

Pharmacy Infoline

Hemophilia and Young Adulthood, Part 1 - Identity, Disclosure & Transitions

BloodStream Media

Hemophilia l Episode 052

Guiding Sol Doula Services

Brian O’Mahony, Origins of Ankle Pain, and Foam Rollers!

BloodStream Media

Science Spotlight lecture: Katherine High, MD

Memorial Sloan Kettering Cancer Center